MAPT and Alzheimer disease: In the context of AD, the A/T/N system – A: Aβ/amyloid-based markers, T: tau/neurofibrillary pathology markers, and N: neurodegenerative or neuronal injury markers – provide a framework for detecting and staging AD [10,11].